Allogene Therapeutics(ALLO) - 2024 Q1 - Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2024 Earnings Conference Call May 13, 2024 5:00 PM ET Company Participants Christine Cassiano - Chief Corporate Affairs & Brand Strategy Officer David Chang - President & Chief Executive Officer Geoff Parker - Chief Financial Officer Zachary Roberts - EVP, Research & Development and Chief Medical Officer Conference Call Participants Michael Yee - Jefferies Tyler Van Buren - TD Cowen Salveen Richter - Goldman Sachs Reni Benjamin - Citizens JMP Luca Issi - RBC Capi ...